Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.

Clinical research challenges posed by difficult-to-treat depression.

Open access
Rush, A. John, Sackeim, Harold A., Conway, Charles R., Bunker, Mark T., Hollon, Steven D., Demyttenaere, Koen, Young, Allan H., Aaronson, Scott T., Dibué, Maxine, Thase, Michael E., McAllister-Williams, R. Hamish · 2022 · Psychological Medicine

Abstract

Approximately one-third of individuals in a major depressive episode will not achieve sustained remission despite multiple, well-delivered treatments. These patients experience prolonged suffering and disproportionately utilize mental and general health care resources. The recently proposed clinical heuristic of ‘difficult-to-treat depression’ (DTD) aims to broaden our understanding and focus attention on the identification, clinical management, treatment selection, and outcomes of such individuals. Clinical trial methodologies developed to detect short-term therapeutic effects in treatment-responsive populations may not be appropriate in DTD. This report reviews three essential challenges for clinical intervention research in DTD: (1) how to define and subtype this heterogeneous group of patients; (2) how, when, and by what methods to select, acquire, compile, and interpret clinically meaningful outcome metrics; and (3) how to choose among alternative clinical trial design options to promote causal inference and generalizability. The boundaries of DTD are uncertain, and an evidence-based taxonomy and reliable assessment tools are preconditions for clinical research and subtyping. Traditional outcome metrics in treatment-responsive depression may not apply to DTD, as they largely reflect the only short-term symptomatic change and do not incorporate durability of benefit, side effect burden, or sustained impact on quality of life or daily function. The trial methodology will also require modification as trials will likely be of longer duration to examine the sustained impact, raising complex issues regarding control group selection, blinding and its integrity, and concomitant treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0033291721004943

Cites

107 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Potential parameters to define DTD or to characterize subgroups.
Fig. 1. Potential parameters to define DTD or to characterize subgroups.CC BY · PubMed Central
Fig. 2. Clinically important outcomes for DTD intervention research. Psych = Psychiatric; Tx = Treatment.
Fig. 2. Clinically important outcomes for DTD intervention research. Psych = Psychiatric; Tx = Treatment.CC BY · PubMed Central
Fig. 3. Application of the pharmaco-psychometric triangle. Note: Figure recreated from Bech et al. (2012). HAM-D6 = Hamilton Rating Scale for Depression 6-item subscale; IDS-C6 = Inventory of Depressive Symptomatology 6-item subscale – Clinician-rated; PRISE = Pragmatic-explanatory continuum indicator summary; Q-LES-Q = Quality of Life Enjoyment and Satisfaction Questionnaire; SR = Sustained release.
Fig. 3. Application of the pharmaco-psychometric triangle. Note: Figure recreated from Bech et al. (2012). HAM-D6 = Hamilton Rating Scale for Depression 6-item subscale; IDS-C6 = Inventory of Depressive Symptomatology 6-item subscale – Clinician-rated; PRISE = Pragmatic-explanatory continuum indicator summary; Q-LES-Q = Quality of Life Enjoyment and Satisfaction Questionnaire; SR = Sustained release.CC BY · PubMed Central
Fig. 4. Pragmatic-explanatory continuum indicator summary (PRECIS) wheel (Thorpe et al., 2009).
Fig. 4. Pragmatic-explanatory continuum indicator summary (PRECIS) wheel (Thorpe et al., 2009).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 105 references

Research works printed but not linked: 3

  1. Hofer, 2012, Handbook of developmental research methods, 3
  2. Thase, 1995, Psychopharmacology: The fourth generation of progress, 1081
  3. 2011, Nonpharmacologic interventions for treatment-resistant depression in adults (comparative effectiveness review number 33)

Cited by

See all 89

Metadata

Authors
Rush, A. J., Sackeim, H. A., Conway, C. R., Bunker, M. T., Hollon, S. D., Demyttenaere, K., Young, A. H., Aaronson, S. T., Dibué, M., Thase, M. E., & McAllister-Williams, R. H.
Affiliations
  • Texas Tech University (US)
  • Columbia University (US)
  • Washington University in St. Louis (US)
  • LivaNova (United States) (US)
  • Vanderbilt University (US)
  • KU Leuven (BE)
  • King's College London (GB)
  • Sheppard and Enoch Pratt Hospital (US)
  • Heinrich Heine University Düsseldorf (DE)
  • University of Pennsylvania (US)
  • Cumbria Northumberland Tyne and Wear NHS Foundation Trust (GB)
Corresponding author
Rush, A. John
Venue
Psychological Medicine
Published
2022-01-07
Volume
52
Issue
3
Pages
419-432
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W4205450793
Cited by
89
References
105
Citations by year
2026: 19 · 2025: 23 · 2024: 17 · 2023: 21 · 2022: 9
FWCI
2.51
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
  • American Foundation for Suicide Prevention
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • Patient-Centered Outcomes Research Institute
  • Stanley Medical Research Institute
  • Foundation for Barnes-Jewish Hospital
  • University of Texas Southwestern Medical Center
  • Sunovion
  • Jazz Pharmaceuticals
  • LivaNova
  • Neurocrine Biosciences
  • Sage Therapeutics
  • Assurex Health
  • National Institute for Health and Care Research (NIHR202380)
  • University of Oxford
  • Otsuka Pharmaceutical
  • European College of Neuropsychopharmacology
  • Servier
  • H. Lundbeck A/S
  • Allergan
  • National Institute of Mental Health
  • Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
difficult-to-treat depression, treatment-resistant depression, major depressive disorder, clinical trial design, outcome measures, patient subtyping, quality of life, blinding, control group selection, concomitant treatment, causal inference
MeSH terms
Depression, Major Depressive Disorder, Humans, Quality of Life, Treatment Outcome, Uncertainty

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical research challenges posed by difficult-to-treat depression. https://app.cochat.ai/papers/10.1017/s0033291721004943
The paper
Rush, A. J., Sackeim, H. A., Conway, C. R., Bunker, M. T., Hollon, S. D., Demyttenaere, K., Young, A. H., Aaronson, S. T., Dibué, M., Thase, M. E., & McAllister-Williams, R. H. (2022). Clinical research challenges posed by difficult-to-treat depression. Psychological Medicine. https://doi.org/10.1017/s0033291721004943

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.